Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Latin America Health Times.
Press releases published on April 24, 2025
Koelis annonce un partenariat avec Bot Image™ lors du congrès de l’AUA 2025
GlobeNewswire
·
April 24, 2025
GRENOBLE, France et PRINCETON, New Jersey, 24 avr. 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (« Koelis » ou la « Société », www.koelis.com), société leader et innovante dans le domaine du traitement des maladies de la prostate, a annoncé ce jour un nouveau …
Best Dental Implants in Seattle Done by Dr. Javadi
GlobeNewswire
·
April 24, 2025
SEATTLE, April 24, 2025 (GLOBE NEWSWIRE) -- Top Seattle periodontist and dental implant surgeon Dr. Ellie Javadi of Orchid Periodontics …
Sharps Technology Announces Reverse Stock Split
GlobeNewswire
·
April 24, 2025
NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: “STSS” and “STSSW”) ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare …
Alkeus Pharmaceuticals Announces Presentations of Gildeuretinol Data During the Research in Vision and Ophthalmology (ARVO) 2025 Annual Meeting May 4-8, 2025
GlobeNewswire
·
April 24, 2025
CAMBRIDGE, Mass., April 24, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that results from its clinical studies of …
OBI Pharma kündigt Posterpräsentationen auf der AACR-Jahrestagung 2025 zu den Antikörper-Wirkstoff-Konjugaten (AWK) OBI-992 und OBI-902, den ADC-Enabling-Technologien GlycOBI® und ThiOBI®, dem Prodrug OBI-3424 und der Globo-H-Forschung (GH-Forschung) a…
GlobeNewswire
·
April 24, 2025
TAIPEH, Taiwan, April 24, 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx: 4174. TWO), hat heute nichtklinische Daten zu OBI-902 bekannt gegeben, einem potenziell in seiner Klasse führenden Anti-TROP2-AWK, das mithilfe der firmeneigenen GlycOBI®- …
OBI Pharma annonce l’exposition d’affiches au congrès annuel de l’AACR 2025 concernant les conjugués anticorps-médicaments (CAM) OBI-992 et OBI-902, les technologies habilitantes relatives aux CAM GlycOBI® et ThiOBI®, le promédicament OBI-3424 et la sc…
GlobeNewswire
·
April 24, 2025
TAIPEI, Taïwan, 24 avr. 2025 (GLOBE NEWSWIRE) -- OBI Pharma, Inc. (TPEx : 4174. TWO) a communiqué aujourd’hui des données non cliniques sur OBI-902, un CAM anti-TROP2 potentiellement le meilleur de sa catégorie, développé à l’aide de la nouvelle génération …
Koelis Announces Partnership with Bot Image™ at AUA 2025
GlobeNewswire
·
April 24, 2025
GRENOBLE, France and PRINCETON, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- Koelis, SAS (“Koelis” or the “Company”, www.koelis.com), a leader and innovator in prostate care, announced today a new partnership with Bot Image™ (Omaha, NE, USA) to serve the …
Verana Health Launches Qdata® Cataracts, the Largest Dataset of Its Kind for Cataract Research
GlobeNewswire
·
April 24, 2025
SAN FRANCISCO, April 24, 2025 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today announced the launch of Qdata® Cataracts, the most comprehensive …
EY US unveils Richard Hall of USOSM as an Entrepreneur Of The Year® 2025 Southwest Award finalist
GlobeNewswire
·
April 24, 2025
IRVING, Texas, April 24, 2025 (GLOBE NEWSWIRE) -- Ernst …
Socially Determined and Acentra Health Partner to Advance Whole Person, Whole Population Healthcare through Enhanced Analytics
GlobeNewswire
·
April 24, 2025
WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Socially Determined, a social risk analytics and solutions company leading the integration of health and social care, and Acentra Health, a technology and health solutions and services company dedicated to …
American Kidney Fund Announces 2025 Class of Corporate Members Providing Support in the Fight Against Kidney Disease
GlobeNewswire
·
April 24, 2025
ROCKVILLE, Md., April 24, 2025 (GLOBE NEWSWIRE) -- Today, the American Kidney Fund (AKF) announces its 2025 Class of Corporate Members who serve as strategic partners in AKF’s Corporate Membership Program. Corporate Members provide vital support to AKF’s …
Healthcare Integrated Technologies Inc. Announces Corporate Name Change to SafeSpace Global Corporation and Ticker Symbol Update
GlobeNewswire
·
April 24, 2025
Company Changes Corporate Name to Align with its AI Products and Core Vision Knoxville, TN, April 24, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, today …
The Love for Liam Foundation to Host the Fourth Annual Liam Johnson Memorial Golf Outing & Benefit Dinner on May 2, 2025
GlobeNewswire
·
April 24, 2025
PHILADELPHIA, April 24, 2025 (GLOBE NEWSWIRE) -- The Love for Liam Foundation, a 501(c)(3) nonprofit that seeks to raise awareness for pediatric epilepsy and drive research funding, today announced the Fourth Annual Liam Johnson Memorial Golf Outing …
Connect Biopharma Announces Multiple Presentations at the American Thoracic Society (ATS) 2025 International Conference
GlobeNewswire
·
April 24, 2025
– Data to be presented supports development of rademikibart for patients with moderate-to-severe asthma or COPD experiencing an acute exacerbation – – Advancing rapid clinical development plan for rademikibart; expect to initiate parallel Phase 2 trials in …
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
GlobeNewswire
·
April 24, 2025
SARASOTA, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: NAYA), formerly known as NAYA Biosciences, Inc., a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, …
Inmagene Reports Topline Results from Phase 2a Study of IMG-007, a Nondepleting Anti-OX40 Monoclonal Antibody with an Extended Half-life, in Patients with Alopecia Areata
GlobeNewswire
·
April 24, 2025
Treatment with three doses of 300 mg (Cohort 1) and 600 mg (Cohort 2) IMG-007 over four weeks resulted in a dose-related clinical activity of hair regrowth. Patients in Cohort 2 showed a sustained improvement in Severity of Alopecia Tool (SALT) score, …
AVITA Medical to Host Acute Wound Care Showcase on May 13, 2025
GlobeNewswire
·
April 24, 2025
VALENCIA, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today announced that it will host its inaugural Acute Wound Care Showcase …
Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia
GlobeNewswire
·
April 24, 2025
HOUSTON, TX, April 24, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced that its proprietary Gen-2 …
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire
·
April 24, 2025
CLEARWATER, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ: APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that …
InnerScope Hearing Technologies (OTC: INND) Announces the Grand Opening of OTCHealthMart.com
GlobeNewswire
·
April 24, 2025
ROSEVILLE, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Via IBN -- InnerScope Hearing Technologies (OTC: INND) is proud to announce the official grand opening of OTCHealthMart.com, a cutting-edge online platform designed to make healthcare products …